Lantern Pharma Inc. (LTRN)
3.65
-0.08 (-2.14%)
At close: Apr 24, 2025, 10:52 AM
Lantern Pharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for LTRN stock have an median target of 25, with a low estimate of 25 and a high estimate of 25. The median target predicts an increase of 584.93% from the current stock price of 3.65.
Latest Analyst Insight Report
According to 2 stock analyst, the rating for Lantern Pharma Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.
Financial Forecast this Year
Revenue This Year
n/a
Revenue Next Year
1.95M
from 0
Increased by -%
EPS This Year
-1.74
from -1930.92
Increased by 99.9%
EPS Next Year
-1.14
from -1.74
Increased by 34.5%